Your browser doesn't support javascript.
loading
TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment.
Zhang, Zhenghou; Zhou, Xiangyu; Guo, Jinshuai; Zhang, Fusheng; Qian, Yiping; Wang, Guang; Duan, Meiqi; Wang, Yutian; Zhao, Haiying; Yang, Zhi; Liu, Zunpeng; Jiang, Xiaofeng.
Afiliação
  • Zhang Z; Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
  • Zhou X; Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
  • Guo J; Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
  • Zhang F; Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
  • Qian Y; Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
  • Wang G; Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
  • Duan M; Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
  • Wang Y; Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
  • Zhao H; Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
  • Yang Z; Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
  • Liu Z; Department of Orthopedics, The Fourth Affiliated Hospital of China Medical University, Shenyang, China. zp_liu@126.com.
  • Jiang X; Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China. 18900912171@163.com.
J Transl Med ; 20(1): 320, 2022 07 16.
Article em En | MEDLINE | ID: mdl-35842634
As an important component of the immunosuppressive tumor microenvironment (TME), it has been established that mesenchymal stem cells (MSCs) promote the progression of tumor cells. MSCs can directly promote the proliferation, migration, and invasion of tumor cells via cytokines and chemokines, as well as promote tumor progression by regulating the functions of anti-tumor immune and immunosuppressive cells. MSCs-derived extracellular vesicles (MSCs-EVs) contain part of the plasma membrane and signaling factors from MSCs; therefore, they display similar effects on tumors in the immunosuppressive TME. The tumor-promoting role of macrophage migration inhibitory factor (MIF) in the immunosuppressive TME has also been revealed. Interestingly, MIF exerts similar effects to those of MSCs in the immunosuppressive TME. In this review, we summarized the main effects and related mechanisms of tumor-associated MSCs (TA-MSCs), TA-MSCs-EVs, and MIF on tumors, and described their relationships. On this basis, we hypothesized that TA-MSCs-EVs, the MIF axis, and TA-MSCs form a positive feedback loop with tumor cells, influencing the occurrence and development of tumors. The functions of these three factors in the TME may undergo dynamic changes with tumor growth and continuously affect tumor development. This provides a new idea for the targeted treatment of tumors with EVs carrying MIF inhibitors.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores Inibidores da Migração de Macrófagos / Células-Tronco Mesenquimais / Vesículas Extracelulares / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores Inibidores da Migração de Macrófagos / Células-Tronco Mesenquimais / Vesículas Extracelulares / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article